Latest Insider Transactions at Molina Healthcare, Inc. (MOH)
This section provides a real-time view of insider transactions for Molina Healthcare, Inc. (MOH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MOLINA HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MOLINA HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
136
-1.16%
|
$39,712
$292.72 P/Share
|
|
Oct 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+5.82%
|
$54,901
$341.91 P/Share
|
|
Oct 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.56%
|
$54,901
$341.91 P/Share
|
|
Oct 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+3.84%
|
$54,901
$341.91 P/Share
|
|
Oct 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
161
+2.31%
|
$54,901
$341.91 P/Share
|
|
Oct 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+1.36%
|
$54,901
$341.91 P/Share
|
|
Oct 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
161
+0.88%
|
$54,901
$341.91 P/Share
|
|
Oct 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
161
+0.92%
|
$54,901
$341.91 P/Share
|
|
Oct 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+1.04%
|
$54,901
$341.91 P/Share
|
|
Aug 15
2024
|
Maurice Hebert Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
393
-3.98%
|
$135,978
$346.52 P/Share
|
|
Jul 30
2024
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
1,000
-5.26%
|
$339,000
$339.21 P/Share
|
|
Jul 29
2024
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,340
-7.47%
|
$1,788,900
$335.0 P/Share
|
|
Jul 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+7.15%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
188
+1.09%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+3.05%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+4.63%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
188
+0.98%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+1.22%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+1.6%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
188
+2.75%
|
$54,896
$292.16 P/Share
|
|
Jul 01
2024
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-2.75%
|
$53,728
$292.16 P/Share
|
|
Jun 28
2024
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69
+0.1%
|
$17,388
$252.71 P/Share
|
|
Jun 28
2024
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69
+0.13%
|
$17,388
$252.71 P/Share
|
|
Jun 28
2024
|
Debra Bacon EVP, Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.19%
|
$3,276
$252.71 P/Share
|
|
May 22
2024
|
James Woys Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.76%
|
$3,450,000
$345.6 P/Share
|
|
May 21
2024
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
250
-1.45%
|
$85,750
$343.27 P/Share
|
|
Apr 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
136
+2.06%
|
$54,944
$404.2 P/Share
|
|
Apr 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+5.69%
|
$54,944
$404.2 P/Share
|
|
Apr 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
136
+0.72%
|
$54,944
$404.2 P/Share
|
|
Apr 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+0.9%
|
$54,944
$404.2 P/Share
|
|
Apr 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+1.18%
|
$54,944
$404.2 P/Share
|
|
Apr 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+3.56%
|
$54,944
$404.2 P/Share
|
|
Apr 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+2.3%
|
$54,944
$404.2 P/Share
|
|
Apr 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
136
+0.78%
|
$54,944
$404.2 P/Share
|
|
Mar 01
2024
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-2.48%
|
$65,790
$387.21 P/Share
|
|
Mar 01
2024
|
Debra Bacon EVP, Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
2,273
+24.93%
|
$879,651
$387.21 P/Share
|
|
Mar 01
2024
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,122
+10.92%
|
$6,239,214
$387.21 P/Share
|
|
Mar 01
2024
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,938
-4.66%
|
$2,298,006
$387.21 P/Share
|
|
Mar 01
2024
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,779
+8.74%
|
$5,719,473
$387.21 P/Share
|
|
Mar 01
2024
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,338
-5.58%
|
$3,226,806
$387.21 P/Share
|
|
Mar 01
2024
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
85,579
+9.74%
|
$33,119,073
$387.21 P/Share
|
|
Mar 01
2024
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,443
-7.88%
|
$23,004,441
$387.21 P/Share
|
|
Mar 01
2024
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,228
+16.59%
|
$8,215,236
$387.16 P/Share
|
|
Mar 01
2024
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,165
-10.07%
|
$3,933,855
$387.21 P/Share
|
|
Mar 01
2024
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,304
+6.95%
|
$891,648
$387.18 P/Share
|
|
Mar 01
2024
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
966
-4.92%
|
$373,842
$387.21 P/Share
|
|
Feb 20
2024
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
1,000
-2.1%
|
$401,000
$401.61 P/Share
|
|
Feb 15
2024
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
1,500
-9.16%
|
$597,000
$398.38 P/Share
|
|
Feb 15
2024
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
750
-3.86%
|
$299,250
$399.12 P/Share
|
|
Feb 14
2024
|
Debra Bacon EVP, Medicaid |
SELL
Open market or private sale
|
Direct |
500
-9.86%
|
$198,000
$396.22 P/Share
|